ARTICLE | Finance

Mpex reprise

Antibiotics play Rempex, a spinout of Mpex assets, raises $67.5M B round

November 14, 2011 8:00 AM UTC

Antibiotics spinout Rempex Pharmaceuticals Inc. came out of stealth mode last week with a series B round of up to $67.5 million.

New investors Frazier Healthcare Ventures and Vivo Ventures joined existing investors SV Life Sciences (SVLS); OrbiMed Advisors; and Adams Street Partners...